Giorgio Minotti Selected Research

Glucose (Dextrose)

10/2023	Cost-Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in China: A New Pillar in Our Pockets, but at What Price?
1/2022	Beyond hypertension: Diastolic dysfunction associated with cancer treatment in the era of cardio-oncology.
11/2021	Sodium-Glucose Cotransporter Inhibitors Reduce Mortality and Morbidity in Patients With Heart Failure: Evidence From a Meta-Analysis of Randomized Trials.
1/2021	Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giorgio Minotti Research Topics

Disease

42	Cardiotoxicity 12/2023 - 09/2002
29	Neoplasms (Cancer) 03/2024 - 09/2003
16	Heart Failure 03/2024 - 06/2004
6	Cardiomyopathies (Cardiomyopathy) 01/2022 - 06/2003
6	Breast Neoplasms (Breast Cancer) 11/2020 - 01/2003
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 07/2010
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 02/2013
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 01/2018
2	Second Primary Neoplasms (Neoplasms, Second) 03/2024 - 01/2022
2	Inflammation (Inflammations) 03/2024 - 06/2002
2	Cytokine Release Syndrome 03/2024 - 01/2022
2	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 01/2016
2	Atrial Fibrillation 01/2023 - 10/2018
2	Hypertension (High Blood Pressure) 01/2022 - 04/2017
2	Myocardial Infarction 12/2021 - 09/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020 - 01/2018
2	Philadelphia Chromosome 01/2020 - 04/2017
2	Tachycardia (Tachyarrhythmias) 01/2019 - 12/2018
2	Infections 01/2018 - 08/2011
1	Neutropenia 10/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023
1	Invasive Fungal Infections 10/2023
1	Cardiac Arrhythmias (Arrythmia) 01/2023
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2023
1	Ventricular Tachycardia 01/2023
1	Vomiting 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Nausea 01/2023
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022
1	Systolic Heart Failure 01/2022
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Pulmonary Embolism 10/2020
1	Venous Thromboembolism 10/2020

Drug/Important Bio-Agent (IBA)

43	AnthracyclinesIBA 12/2023 - 09/2002
27	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 09/2002
7	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2012 - 04/2004
6	IronIBA 01/2008 - 06/2002
5	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2017
5	Antineoplastic Agents (Antineoplastics)IBA 09/2013 - 06/2004
5	Epirubicin (Ellence)FDA LinkGeneric 05/2012 - 06/2004
5	quinone (benzoquinone)IBA 01/2010 - 01/2004
4	SodiumIBA 10/2023 - 01/2021
4	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 01/2021
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 04/2017
4	Trastuzumab (Herceptin)FDA Link 04/2019 - 01/2007
4	pixantrone (BBR 2778)IBA 01/2018 - 02/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2007 - 01/2003
3	Ranolazine FDA Link 01/2022 - 09/2013
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2018
3	ponatinibIBA 01/2020 - 04/2017
3	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2018 - 02/2013
3	AnthraquinonesIBA 01/2018 - 02/2013
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2013 - 06/2009
3	adriamycinolIBA 02/2013 - 07/2006
3	hydroquinone (Esoterica)FDA Link 01/2010 - 01/2008
3	taxaneIBA 02/2007 - 07/2006
2	Chimeric Antigen ReceptorsIBA 03/2024 - 11/2023
2	Troponin IIBA 03/2024 - 12/2018
2	Sodium-Glucose Transport ProteinsIBA 10/2023 - 11/2021
2	midostaurinIBA 10/2023 - 01/2021
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023 - 10/2018
2	ibrutinibIBA 01/2023 - 10/2018
2	Monoclonal AntibodiesIBA 01/2022 - 01/2019
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 11/2020
2	AnticoagulantsIBA 10/2020 - 10/2018
2	TroponinIBA 12/2018 - 11/2017
2	Superoxides (Superoxide)IBA 02/2013 - 05/2012
2	liposomal doxorubicin (Doxil)FDA Link 12/2012 - 11/2011
2	AntioxidantsIBA 01/2010 - 09/2002
2	Free RadicalsIBA 01/2008 - 06/2004
2	Taxoids (Taxanes)IBA 02/2007 - 01/2007
2	Docetaxel (Taxotere)FDA Link 02/2007 - 07/2006
2	ferrylmyoglobinIBA 02/2004 - 09/2002
2	Aconitate Hydratase (Aconitase)IBA 06/2003 - 06/2002
1	Natriuretic PeptidesIBA 03/2024
1	Digoxin (Digitek)FDA LinkGeneric 03/2024
1	DiureticsIBA 03/2024
1	Sodium-Glucose Transporter 2 InhibitorsIBA 10/2023
1	posaconazole FDA Link 10/2023
1	Micafungin (FK463)FDA Link 10/2023
1	Palonosetron (Aloxi)FDA Link 01/2023
1	tafasitamabIBA 01/2022
1	loncastuximab tesirineIBA 01/2022
1	blinatumomabIBA 01/2022
1	Lenalidomide (CC 5013)FDA Link 01/2022
1	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2022
1	Phosphodiesterase InhibitorsIBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 12/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2021
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2020

Therapy/Procedure

23	Therapeutics 03/2024 - 04/2006
13	Drug Therapy (Chemotherapy) 03/2024 - 07/2006
2	Drug Tapering 01/2023 - 07/2010
1	Precision Medicine 01/2021
1	Long-Term Care 12/2020